• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study.

作者信息

Batista Thales Paulo

机构信息

Department of Surgery/Oncology, Faculdade Pernambucana de Saúde, Instituto de Medicina Integral Professor Fernando Figueira - FPS/IMIP, Recife, PE, Brazil.

Department of Gynecology, Hospital de Câncer de Pernambuco - HCP, Recife, PE, Brazil.

出版信息

Ann Surg Oncol. 2017 Dec;24(Suppl 3):630. doi: 10.1245/s10434-017-6151-5. Epub 2017 Nov 1.

DOI:10.1245/s10434-017-6151-5
PMID:29094252
Abstract
摘要

相似文献

1
Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study.关于《复发性上皮性卵巢癌的手术及腹腔热灌注化疗：一项前瞻性随机III期研究》的评论
Ann Surg Oncol. 2017 Dec;24(Suppl 3):630. doi: 10.1245/s10434-017-6151-5. Epub 2017 Nov 1.
2
Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al.斯皮利蒂斯等人的前瞻性随机 3 期研究中复发性卵巢癌中腹腔内热化疗的作用简要报告
Int J Gynecol Cancer. 2017 Feb;27(2):246-247. doi: 10.1097/IGC.0000000000000864.
3
Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.减瘤手术及腹腔热灌注化疗治疗复发性上皮性卵巢癌：一项前瞻性随机III期研究
Ann Surg Oncol. 2015 May;22(5):1570-5. doi: 10.1245/s10434-014-4157-9. Epub 2014 Nov 13.
4
Survival Analysis in a Randomized Trial of HIPEC in Ovarian Cancer.卵巢癌腹腔热灌注化疗随机试验中的生存分析
Ann Surg Oncol. 2017 Dec;24(Suppl 3):631. doi: 10.1245/s10434-017-6129-3. Epub 2017 Oct 13.
5
Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.微创二次肿瘤细胞减灭术联合腹腔热灌注化疗与开放性手术联合腹腔热灌注化疗治疗卵巢癌孤立性复发的比较：一项关于围手术期结局的回顾性队列研究
J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):428-32. doi: 10.1016/j.jmig.2014.11.008. Epub 2014 Nov 26.
6
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.HIPEC ROC I：一项关于顺铂的I期研究，该研究针对铂敏感复发性上皮性卵巢癌患者，在术中进行高温腹腔内化疗灌注顺铂，术后进行静脉铂类化疗。
Int J Cancer. 2015 Feb 1;136(3):699-708. doi: 10.1002/ijc.29011. Epub 2014 Jun 17.
7
The role of cytoreductive surgery and HIPEC in epithelial ovarian cancer.肿瘤细胞减灭术和腹腔热灌注化疗在上皮性卵巢癌中的作用。
J BUON. 2015 May;20 Suppl 1:S12-28.
8
The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction.紫杉醇腹腔热灌注化疗在铂敏感复发性上皮性卵巢癌患者减瘤术后微小残留病灶中的作用。
Ann Surg Oncol. 2015 Mar;22(3):987-93. doi: 10.1245/s10434-014-4049-z. Epub 2014 Sep 12.
9
Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.原发性或继发性肿瘤细胞减灭术联合术中腹腔内热灌注化疗（HIPEC）治疗晚期上皮性卵巢癌。
Minerva Ginecol. 2017 Apr;69(2):119-127. doi: 10.23736/S0026-4784.16.03959-9. Epub 2016 Jul 14.
10
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.微创二次细胞减灭术联合 HIPEC 治疗复发性卵巢癌：病例系列研究。
Gynecol Oncol. 2014 Feb;132(2):303-6. doi: 10.1016/j.ygyno.2013.12.028. Epub 2013 Dec 27.

引用本文的文献

1
Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis.高热术中腹腔化疗联合细胞减灭术治疗腹膜转移患者的系统评价和成本效果分析。
Health Technol Assess. 2024 Sep;28(51):1-139. doi: 10.3310/KWDG6338.
2
Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS.完全细胞减灭术（CRS）后腹腔热灌注化疗（HIPEC）在铂敏感复发性卵巢癌（OC）腹膜复发中的作用：两个CRS参考中心的标准化目标
Cancers (Basel). 2023 Jan 7;15(2):405. doi: 10.3390/cancers15020405.
3
The current role of secondary cytoreductive surgery for recurrent ovarian cancer.
二次减瘤手术在复发性卵巢癌中的当前作用。
Front Oncol. 2022 Oct 21;12:1029976. doi: 10.3389/fonc.2022.1029976. eCollection 2022.
4
The Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer-Hyperthermia versus Normothermia: A Randomized Controlled Trial.紫杉醇术中腹腔内化疗在卵巢癌腹膜转移瘤手术治疗中的作用——热疗与常温治疗：一项随机对照试验
J Clin Med. 2022 Sep 29;11(19):5785. doi: 10.3390/jcm11195785.
5
No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study.间隔减瘤手术后腹腔热灌注化疗在晚期卵巢癌治疗中无明显优势：一项回顾性研究。
Front Surg. 2022 Sep 12;9:997344. doi: 10.3389/fsurg.2022.997344. eCollection 2022.
6
Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials.腹腔内热灌注化疗（HIPEC）治疗原发性晚期和复发性卵巢癌的管理：随机试验的系统评价和荟萃分析。
ESMO Open. 2022 Oct;7(5):100586. doi: 10.1016/j.esmoop.2022.100586. Epub 2022 Sep 16.
7
Can HIPEC be used against platinum-resistance and for inducing sensitivity to PARP inhibitors in ovarian cancer?腹腔热灌注化疗（HIPEC）能否用于对抗卵巢癌中的铂耐药性并诱导对聚（ADP-核糖）聚合酶（PARP）抑制剂的敏感性？
Cancer Drug Resist. 2020 Jul 10;3(3):666-671. doi: 10.20517/cdr.2020.27. eCollection 2020.
8
Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer.手术和腹腔内热化疗在卵巢癌中的作用。
ESMO Open. 2021 Jun;6(3):100149. doi: 10.1016/j.esmoop.2021.100149. Epub 2021 May 10.
9
Narrative review of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian cancer: a critical reappraisal of the current evidence.晚期卵巢癌患者腹腔热灌注化疗（HIPEC）的叙述性综述：对当前证据的批判性重新评估
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S182-S188. doi: 10.21037/jgo-20-130.
10
Development of new medical treatment for epithelial ovarian cancer recurrence.上皮性卵巢癌复发新疗法的研发。
Gland Surg. 2020 Aug;9(4):1149-1163. doi: 10.21037/gs-20-413.